Companies /Healthcare

Veeva Systems Inc - Class A

NYSE: VEEV Health Information Services
$285.80
â–² $40.89 (+16.69%) today
Markets open · 1:15pm ET

Q2 2026 Earnings

Reported Aug 27, 2025, 4:05pm ET · SEC source
$1.99
Beat +4.73%
EPS · est. $1.90
$789.1M
Beat +2.65%
Revenue · est. $768.7M
+6.7%
Beating market
VEEV vs S&P since report
7 quarters
Consecutive EPS beats

Market Reaction

% change · around the report
−3%0+3%+6%Aug 27Aug 28report 4:05pm ETearnings+0.4%−2.7%
−3%0+3%+6%Aug 27Aug 28earnings+0.4%−2.7%
VEEV −2.7%S&P 500 +0.4%
−3%0+3%+6%Aug 27Aug 28report 4:05pm ETearnings+0.6%−2.7%
−3%0+3%+6%Aug 27Aug 28earnings+0.6%−2.7%
VEEV −2.7%NASDAQ +0.6%
−4%0+4%Aug 26Sep 4report 4:05pm ETearnings+0.5%−4.6%
−4%0+4%Aug 26Sep 4earnings+0.5%−4.6%
VEEV −4.6%S&P 500 +0.5%
−4%0+4%Aug 26Sep 4report 4:05pm ETearnings+0.7%−4.6%
−4%0+4%Aug 26Sep 4earnings+0.7%−4.6%
VEEV −4.6%NASDAQ +0.7%
−7.24%
Day of report
−1.15%
Next session
+0.22%
One week
+9.39%
30 days

S&P 500 over the same 30 days: +2.66%.

Did VEEV Beat Earnings? Q2 2026 Results

Veeva Systems posted a clean beat across the board in fiscal Q2 2026, with non-GAAP diluted EPS of $1.99 coming in 4.73% ahead of the $1.90 consensus estimate while revenue of $789.08 million topped expectations by 2.65% and grew 16.7% year over year. The standout driver behind the quarter's momentum was accelerating operating leverage — non-GAAP operating margin expanded to 44.7% from 41.4% a year ago — as the company's Vault CRM platform reached a significant inflection point, with over 100 customers live and seven of the top 20 biopharmas committed to the platform. A landmark partnership with IQVIA, which resolves all pending litigation between the two companies and enables seamless product interoperability, removed a meaningful competitive overhang heading into the back half of the fiscal year. Veeva raised its full-year fiscal 2026 revenue guidance to $3.13–$3.14 billion and non-GAAP EPS to approximately $7.78, while guiding Q3 revenue to $790–$793 million and EPS of $1.94–$1.95.

Key Takeaways
  • Subscription services revenue growth of 17% year over year to $659.2 million
  • Non-GAAP operating margin expanded to 44.7% from 41.4% year over year
  • Broad-based strength across all metrics, outperforming guidance
  • Vault CRM now has more than 100 customers live

“It's exciting to see our vision of connected software, data, and business consulting for life sciences becoming a reality.”

Veeva Systems CEO, on the earnings call

Forward Guidance & Outlook

For fiscal Q3 2026 (ending October 31, 2025), Veeva guided total revenues of $790–$793 million, non-GAAP operating income of $348–$350 million, and non-GAAP fully diluted EPS of $1.94–$1.95. For full fiscal year 2026 (ending January 31, 2026), the company raised guidance to total revenues of $3,134–$3,140 million, non-GAAP operating income of approximately $1,388 million, and non-GAAP fully diluted EPS of approximately $7.78.

VEEV YoY Financials

Q2 2026 vs Q2 2025 · SEC filings Q2 2025 Q2 2026
$0$300.0M$600.0M$676.2M$789.1MRevenue$505.8M$593.8MGross Profit$166.5M$195.9MOperating Income$171.0M$200.3MNet Income
$0$300.0M$600.0MRevenueGross ProfitOperating IncomeNet Income

VEEV Revenue by Segment

Subscription Services$659.2M+17.0%
Veeva R&D Solutions - Subscription$351.7M
Veeva Commercial Solutions - Subscription$307.5M
Professional Services and Other$129.9M
Veeva R&D Solutions - Professional Services$82.2M
Veeva Commercial Solutions - Professional Services$47.7M

Figures from SEC filings and company reports. Not investment advice.